The swinging thyroid in hepatitis C infection and interferon therapy

Area of Science:

• Endocrinology
• Hepatology
• Pharmacology

Background:

• Chronic hepatitis C infection is often treated with interferon alfa-2b and ribavirin.
• Thyroid dysfunction is a known potential side effect of this antiviral therapy.
• A triphasic thyroid response is a rare but documented phenomenon.

Purpose of the Study:

• To describe a unique case of triphasic thyroid response in a patient treated for chronic hepatitis C.
• To highlight the distinct phases of thyroid dysfunction observed.
• To discuss the implications for patient management and understanding disease pathogenesis.

Main Methods:

• Case report of a 53-year-old male patient.
• Monitoring of thyroid function during and after interferon alfa-2b and ribavirin therapy.
• Diagnostic workup including thyroid scan and thyroid stimulating immunoglobulin levels.
• Treatment with thiourea for Graves-like thyrotoxicosis.

Main Results:

• The patient developed biphasic thyroiditis during treatment.
• Post-treatment, he exhibited T3-Graves-like thyrotoxicosis confirmed by imaging and serology.
• Rapid remission was achieved with thiourea treatment for presumed de novo Graves' disease.

Conclusions:

• This case represents a rare triphasic thyroid response to hepatitis C treatment.
• It underscores the importance of continued thyroid monitoring post-therapy.
• Tailored management specific to each thyroid phase is crucial for optimal outcomes.